Value Evidence Communication
We believe that a credible value story requires a deep understanding of how ‘value’ is perceived by patients, providers, payers, and policymakers. It requires local knowledge of the product, care, and regulatory landscape.
At Excelra, we apply this understanding to package analytical insights into coherent and impactful global value dossiers, slide presentations and other market access collaterals, tailor-made to the intended target audience.
WEAVING A LUCID AND PERSUASIVE VALUE STORY
The core value/reimbursement dossier includes a comprehensive repository of evidence supportive of the product value story, inclusive of the disease background, treatment guidelines, unmet needs, product information, burden of illness, clinical summaries, economic models, and indirect treatment comparisons for the intervention in the target population. At Excelra, we apply this understanding to package analytical insights for drugs and medical device appraisals into coherent and impactful value dossiers, slide presentations and other market access collaterals, tailor-made to the intended target audience, whether this is for health technology assessment (HTA) submissions (AMCP dossier, NICE submission dossier, CADTH submission dossier, etc.), internal stakeholders or other policy makers.